Formulation and Stability of Solutions.
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to prevent inadvertent microbial contamination issues. The first in this series of articles took us through a discussion of optimizing the physical stability of solutions. This article concludes this series of articles with a discussion on foreign particles, protein aggregation, and immunogenicity; optimizing microbiological activity; and osmolality (tonicity) agents, and discusses how these challenges and issues are addressed.
Michael J
MJ
Akers
D000327:Adsorption; D002626:Chemistry, Pharmaceutical; D004355:Drug Stability; D019999:Pharmaceutical Solutions / Q000737:chemistry*; D011310:Preservatives, Pharmaceutical / Q000494:pharmacology; D066329:Protein Aggregates; D012996:Solutions
D019999:Pharmaceutical Solutions; D011310:Preservatives, Pharmaceutical; D066329:Protein Aggregates; D012996:Solutions